Everyone knows what will happen to the stock price
Post# of 148391
(Total Views: 622)
Posted On: 02/19/2021 12:15:49 PM
Re: craigakess #78658
Everyone knows what will happen to the stock price of CYDY when we get the great news from the CD12 trials. Many large fortunes will be made and the market cap of Cytodyn will skyrocket. Only the lack of that "little bit" of certainty is keeping the SP down.
Unblinding of the CD12 data to Cytodyn and the FDA would be a huge benchmark to note and celebrate. It may have happened just when NP said it would. But along with the unblinding comes the certainty of the efficacy of Leronlimab against Covid.
Many may say, "Yeah, great, that is what we want!" But, no, that is not what we want.
We, above all, want approval of Leronlimab by the FDA. We also want the listing of Cytodyn on NASDAQ. Both of these things are put in jeopardy by the premature release of what is, by all accounts, insider information until there is a formal, public announcement of the CD12 results.
Everyone in Cytodyn, with the unblinding of CD12 data, is carrying around dangerous information. This is insider information. If anyone leaks the CD12 data and someone starts buying stock as a result, they can go to jail. If they jeopardize the FDA approval or NASDAQ uplisting, they can be sued bigtime.
Company silence is totally understandable. If you don't like it, invest where your Grandma does.
I have invested before there is total certainty of CD12 results. I have put my money where my mouth is. If you can't even take the risk of a farmer who plants his or her crops, not knowing what Mother Nature may throw at them, you don't deserve the rewards of the harvest.
If you want to whine and cry about Nader and the FDA or NASDAQ, please go elsewhere. You are not doing anything to earn the money you may recieve as a result of investing in Cytodyn. With the information you have, you make a choice and you take a risk, YOUR risk! What else have you done to expect a reward?
Unblinding of the CD12 data to Cytodyn and the FDA would be a huge benchmark to note and celebrate. It may have happened just when NP said it would. But along with the unblinding comes the certainty of the efficacy of Leronlimab against Covid.
Many may say, "Yeah, great, that is what we want!" But, no, that is not what we want.
We, above all, want approval of Leronlimab by the FDA. We also want the listing of Cytodyn on NASDAQ. Both of these things are put in jeopardy by the premature release of what is, by all accounts, insider information until there is a formal, public announcement of the CD12 results.
Everyone in Cytodyn, with the unblinding of CD12 data, is carrying around dangerous information. This is insider information. If anyone leaks the CD12 data and someone starts buying stock as a result, they can go to jail. If they jeopardize the FDA approval or NASDAQ uplisting, they can be sued bigtime.
Company silence is totally understandable. If you don't like it, invest where your Grandma does.
I have invested before there is total certainty of CD12 results. I have put my money where my mouth is. If you can't even take the risk of a farmer who plants his or her crops, not knowing what Mother Nature may throw at them, you don't deserve the rewards of the harvest.
If you want to whine and cry about Nader and the FDA or NASDAQ, please go elsewhere. You are not doing anything to earn the money you may recieve as a result of investing in Cytodyn. With the information you have, you make a choice and you take a risk, YOUR risk! What else have you done to expect a reward?
(33)
(4)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼